MSB 1.86% $1.32 mesoblast limited

MSB Trading - 2020, page-5716

  1. 12,909 Posts.
    lightbulb Created with Sketch. 190
    We get a mention in the https://www.washingtonpost.com/business/2020/04/16/coronavirus-drug-treatment/

    Here are the drugs that could treat coronavirus. But don’t expect a silver bullet.

    Despite Trump’s boosterism, there are no treatments ready to fight covid-19



    STEM CELL TREATMENTS — At least two companies, Mesoblast and Celularity, are investigating the use of stem cells to fight the excessive immune system response in covid-19 patients. Mesoblast said this month it has received FDA approval to begin human testing. Celularity is partnering with Maryland-based United Therapeutics
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.